Patients with chronic spontaneous urticaria experienced substantial reductions in hives and itch with briquilimab through 16 ...

AYVAKIT's multibillion-dollar potential and BLU-808 breakthroughs drive BPMC's meteoric rise in biotech innovation.

Morgan Stanley analyst Michael Ulz has maintained their neutral stance on BPMC stock, giving a Hold rating on January 9.Stay Ahead of the ...

Allergy and immunology lost a pioneer last summer with the death of Marcus Maurer, MD, executive director of the Institute of Allergology at Charité University Medicine, Berlin. Maurer was an author ...

Researchers identify a pathogenic subset of CD8+ memory T-cells that promote airway tissue inflammation and recurrent ...

Investing.com -- Shares of Blueprint Medicines (NASDAQ: BPMC) Corporation (NASDAQ:BPMC) climbed 17% as the company outlined its growth strategy for 2025, highlighting the potential of its systemic ...

A recent study published in Science Translational Medicine has examined a new approach to address inflammatory skin diseases, such as dermatitis and rosacea, by focusing on a specific glutamate ...

Shares of Blueprint Medicines BPMC rallied 18.2% on Monday driven by investor enthusiasm following the company’s announcement ...

Indeed, a recent study published in the journal Arteriosclerosis, Thrombosis, and Vascular Biology found a prolonged ...

Talia Lavin, 42, from Massachusetts, US, was prescribed the antibiotic Ciprofloxacin for a urinary tract infection - but the ...

Researchers find that allergy medicine could help patients with a rare genetic disease avoid liver transplants.